Navigation Links
Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
Date:10/2/2007

oll-free 1-800-408-3053

----------------------------------------------------------

Pin Code 3238234 followed by the number sign

----------------------------------------------------------

Vasogen also announced today that its President and Chief Executive Officer, Chris Waddick, will present a Company overview at Bio InvestorForum 2007 on October 10, 2007, at 12:15 p.m. Pacific Time (3:15 p.m. ET) at the Palace Hotel, San Francisco. A live audio web cast and slide presentation of this event can be accessed through Vasogen's Website at: http://www.vasogen.com. An archived replay will be available following the presentation.

About Vasogen:

Vasogen is a biotechnology company engaged in the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. The Company's lead product, the Celacade(TM) technology, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade is in late-stage development for the treatment of chronic heart failure and has received European regulatory approval under the CE Mark for this indication. Vasogen is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders and is preparing to advance VP025, the lead drug candidate from this new class, into phase II development.

Certain statements contained in this press release, the upcoming conference call and webcasts, or elsewhere in our public documents constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or "forward-looking information" under the Securities Act (Ontario). These statements may include, without limitation, pl
'/>"/>

SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... 8 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... financial results for the second quarter of fiscal ... "After rigorous evaluation of numerous global in-licensing opportunities, ... Melbourne -based drug development company, into YM ... , Chairman & CEO of YM BioSciences Inc. ...
(Date:2/8/2010)... , Feb. 8 Biocell ... with maternal-fetal-medicine doctors by attending the Society for ... has been working with perinatologists and Ob/Gyn doctors ... , CEO of Biocell Center Corporation. "We understand ... mothers and families and we are hoping to ...
(Date:2/8/2010)... to present the critical processes that comprise a more accurate ... ... Chicago, IL (PRWEB) February 8, 2010 ... software, today announced that both Kristin Lucas and Kelly Larrabee, ... at the CBI Forecasting & Budgeting conference at the Marriott ...
(Date:2/8/2010)... announce that it has hired Lisa Wichman and Sahar Meyer to its ... an Account Manager and will focus on key healthcare markets in the ... that group Omaha, NE. , ... Foothill Ranch, CA (Vocus) February 8, ... the hiring of a new Account Manager and Manager of Analytics. , ...
Breaking Biology Technology:YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 2Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 3
... and MTAX: CTIC) management to hold a conference call ... update on Zevalin asset,purchase, CMS reimbursement, and PIX301 timing ... December 27 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 ... at http://www.cticseattle.com - webcast will ...
... RICHMOND, Va., Dec. 26 Insmed Inc. (Nasdaq:,INSM), ... that it has requested a hearing before a ... Determination to delist the,Company,s common stock from the ... from the Nasdaq Stock Market ("Nasdaq") on,December 20, ...
... CEO -, DALLAS, Dec. 26 Access Pharmaceuticals, ... Jeffrey B.,Davis has been appointed to the additional role ... CEO of the Company for health reasons. Mr.,Seiler has ... believe that Access has an exciting future with ProLindac(TM),MuGard(TM), ...
Other Biology Technology:Insmed to Appeal Delisting Notification From Nasdaq 2Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 2Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 3
(Date:2/8/2010)... to a significantly elevated risk of having a child ... an exhaustive study of all births in California during ... paternal age is associated with elevated autism risk only ... under 30, the study found. , Published online today ... Research, the study, "Independent and Dependent Contributions of ...
(Date:2/7/2010)... (NCI) have found that the prevalence of tamoxifen use ... a personal history of breast cancer is very low. ... breast cancer in women who are at increased risk ... published in the February issue of Cancer Epidemiology, ... Association for Cancer Research. , The low prevalence ...
(Date:2/7/2010)... Consuming two or more soft drinks per week increased ... compared to individuals who did not consume soft drinks, ... & Prevention , a journal of the American Association ... cancer remains one of the most deadly, and only ... five years later. , Mark Pereira, Ph.D., senior author ...
Breaking Biology News(10 mins):UC Davis study confirms link between advanced maternal age and autism 2UC Davis study confirms link between advanced maternal age and autism 3UC Davis study confirms link between advanced maternal age and autism 4Few women take tamoxifen to prevent breast cancer 2Soft drink consumption may increase risk of pancreatic cancer 2Perfect Fathers Day Gift 3A The Sound of Silence 47810 1Perfect Fathers Day Gift 3A The Sound of Silence 47810 2Perfect Fathers Day Gift 3A The Sound of Silence 47810 3Two Drugs Better Than One for Crohns Patients 47809 1Two Drugs Better Than One for Crohns Patients 47809 2Two Drugs Better Than One for Crohns Patients 47809 3Pay for Performance Doesnt Shortchange Patients 47807 1Pay for Performance Doesnt Shortchange Patients 47807 2Pay for Performance Doesnt Shortchange Patients 47807 3
... research has shown that reduced calorie intake can increase ... and his collaborators* have discovered that reducing calorie intake ... health and longevity benefits of life-long calorie reduction. Importantly, ... using this knowledge to establish a novel screening technique ...
... according to scientific gospel, social behavior is dictated primarily ... reproduction. , That may well be true for many ... the University of Wisconsin-Madison have found evidence that social ... be with one another. What's more, the researchers say, ...
... a unique protein from jellyfish that could be inserted ... cause them to radiate a brilliant green color. This ... many new discoveries regarding how living cells function. But ... detection: plants harbor tough cell walls and enormous ...
Other Biology News:It's never too late to get it back! Aging interrupted 2In young mice, gregariousness seems to reside in the genes 2In young mice, gregariousness seems to reside in the genes 3
... system uses three Adept CE 4100 high ... rate in one microlitre increaments. The Adept ... System control and data processing is provided ... CE 4900., Column heater/chillers can be supplied. ...
... of samples may be carried out using this ... System control and data processing is provided ... The elegant, powerful and very easy to use ... and 2000., The supplied detector is the ground ...
... The Adept HPLC range has ... Q-Adept systems, a quaternary low ... binary low pressure mixing pump. ... compact systems add even more ...
Narrow-mouth has heavy-duty rim. Approximate graduations are in durable white enamel. Extra large marking space. capacity 125 mL Special grade: student grade...
Biology Products: